$2.45T
Total marketcap
$61.21B
Total volume
BTC 50.61%     ETH 15.74%
Dominance

Proteomics International Laboratories Limited PIQ.AX Stock

1.16 AUD {{ price }} -4.545460% {{change_pct}}%
COUNTRY
Australia
Exchange
ASX
Market Cap
151.18M AUD
LOW - HIGH [24H]
1.15 - 1.2 AUD
VOLUME [24H]
215.14K AUD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.05 AUD

Proteomics International Laboratories Limited Price Chart

Proteomics International Laboratories Limited PIQ.AX Financial and Trading Overview

Proteomics International Laboratories Limited stock price 1.16 AUD
Previous Close 0.83 AUD
Open 0.83 AUD
Bid 0.84 AUD x 0
Ask 0.85 AUD x 0
Day's Range 0.82 - 0.84 AUD
52 Week Range 0.61 - 1.18 AUD
Volume 63.01K AUD
Avg. Volume 80.4K AUD
Market Cap 101.54M AUD
Beta (5Y Monthly) 0.603
PE Ratio (TTM) N/A
EPS (TTM) -0.05 AUD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 2.42 AUD

PIQ.AX Valuation Measures

Enterprise Value 95.52M AUD
Trailing P/E N/A
Forward P/E -27.666666
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 31.919806
Price/Book (mrq) 12.028986
Enterprise Value/Revenue 30.027
Enterprise Value/EBITDA -16.367

Trading Information

Proteomics International Laboratories Limited Stock Price History

Beta (5Y Monthly) 0.603
52-Week Change N/A
S&P500 52-Week Change N/A
52 Week High 1.18 AUD
52 Week Low 0.61 AUD
50-Day Moving Average 0.91 AUD
200-Day Moving Average 0.89 AUD

PIQ.AX Share Statistics

Avg. Volume (3 month) 80.4K AUD
Avg. Daily Volume (10-Days) 71.5K AUD
Shares Outstanding 122.34M
Float 78.77M
Short Ratio N/A
% Held by Insiders 35.27%
% Held by Institutions 0.67%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends June 30, 2023
Most Recent Quarter (mrq) June 30, 2023
Next Fiscal Year End June 30, 2024

Profitability

Profit Margin -194.16%
Operating Margin (ttm) -96.44%
Gross Margin 26.26%
EBITDA Margin -183.46%

Management Effectiveness

Return on Assets (ttm) -51.42%
Return on Equity (ttm) -106.41%

Income Statement

Revenue (ttm) 3.18M AUD
Revenue Per Share (ttm) 0.03 AUD
Quarterly Revenue Growth (yoy) -13.30%
Gross Profit (ttm) 835.59K AUD
EBITDA -5836071 AUD
Net Income Avi to Common (ttm) -6176573 AUD
Diluted EPS (ttm) -0.05
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 6.03M AUD
Total Cash Per Share (mrq) 0.05 AUD
Total Debt (mrq) 64.09K AUD
Total Debt/Equity (mrq) 0.77 AUD
Current Ratio (mrq) 7.551
Book Value Per Share (mrq) 0.069

Cash Flow Statement

Operating Cash Flow (ttm) -5692911 AUD
Levered Free Cash Flow (ttm) -5020831 AUD

Profile of Proteomics International Laboratories Limited

Country Australia
State WA
City Perth
Address QEII Medical Centre
ZIP 6009
Phone 61 8 9389 1992
Website https://www.proteomics.com.au
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees N/A

Proteomics International Laboratories Limited operates as a medical technology company with a focus on the area of proteomics. It provides PromarkerD, a predictive test for diabetic kidney disease; and develops diagnostic tests for endometriosis and giardia. The company also offers analytical services, including specialist contract research. The company was founded in 2001 and is based in Perth, Australia.

Q&A For Proteomics International Laboratories Limited Stock

What is a current PIQ.AX stock price?

Proteomics International Laboratories Limited PIQ.AX stock price today per share is 1.16 AUD.

How to purchase Proteomics International Laboratories Limited stock?

You can buy PIQ.AX shares on the ASX exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Proteomics International Laboratories Limited?

The stock symbol or ticker of Proteomics International Laboratories Limited is PIQ.AX.

Which industry does the Proteomics International Laboratories Limited company belong to?

The Proteomics International Laboratories Limited industry is Biotechnology.

How many shares does Proteomics International Laboratories Limited have in circulation?

The max supply of Proteomics International Laboratories Limited shares is 130.89M.

What is Proteomics International Laboratories Limited Price to Earnings Ratio (PE Ratio)?

Proteomics International Laboratories Limited PE Ratio is now.

What was Proteomics International Laboratories Limited earnings per share over the trailing 12 months (TTM)?

Proteomics International Laboratories Limited EPS is -0.05 AUD over the trailing 12 months.

Which sector does the Proteomics International Laboratories Limited company belong to?

The Proteomics International Laboratories Limited sector is Healthcare.